The effects of prognostic factors on transplant and mortality of patients with end-stage liver disease using Markov multistate model

被引:0
作者
Madreseh, Elham [1 ,2 ]
Mahmoudi, Mahmood [1 ]
Toosi, Mohssen Nassiri [3 ]
Abolghasemi, Jamileh [4 ]
Zeraati, Hojjat [1 ]
机构
[1] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran
[2] Univ Tehran Med Sci, Rheumatol Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Liver Transplantat Res Ctr, Imam Khomeini Hosp Complex, Tehran, Iran
[4] Iran Univ Med Sci, Sch Publ Hlth, Dept Biostat, Tehran, Iran
来源
JOURNAL OF RESEARCH IN MEDICAL SCIENCES | 2023年 / 28卷 / 01期
关键词
Cirrhosis; life expectancy; model for end-stage liver disease; survival; LONG-TERM SURVIVAL; WAITING-LIST; LIFE EXPECTANCY; MELD; RECIPIENTS; CIRRHOSIS; SCORE; BENEFIT; HEALTH; STATES;
D O I
10.4103/jrms.jrms_1091_21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Decompensated cirrhosis patients have a high risk of death which can be considerably reduced with liver transplantation (LT). This study aimed to simultaneously investigate the effect of some patients' characteristics on mortality among those with/without LT and also LT incident.Materials and Methods: In this historical cohort study, the information from 780 eligible patients aged 18 years or older was analyzed by the Markov multistate model; they had been listed between 2008 and 2014, needed a single organ for initial orthotopic LT, and followed at least for up to 5 years.Results: With a median survival time of 6 (5-8) years, there were 275 (35%) deaths. From 255 (33%) patients who had LT, 55 (21%) subsequently died. Factors associated with a higher risk of mortality and LT occurrence were included: higher model for end-stage liver disease (MELD) score (hazard ratio [HR] = 1.16, confidence interval [CI]: 1.09-1.24 and HR = 1.22, CI: 1.41-1.30) and ascites complication (HR = 2.34, CI: 1.74-3.16 and HR = 11.43, CI: 8.64-15.12). Older age (HR = 1.03, CI: 1.01-1.06), higher creatinine (HR = 6.87, CI: 1.45-32.56), and autoimmune disease versus hepatitis (HR = 2.53, CI: 1.12-5.73) were associated with increased risk of mortality after LT.Conclusion: The MELD and ascites are influential factors on waiting list mortality and occurrence of LT. Total life expectancy is not influenced by higher MELD.
引用
收藏
页数:11
相关论文
共 55 条
  • [1] COMPETING RISKS DETERMINING EVENT-FREE SURVIVAL IN EARLY BREAST-CANCER
    ARRIAGADA, R
    RUTQVIST, LE
    KRAMAR, A
    JOHANSSON, H
    [J]. BRITISH JOURNAL OF CANCER, 1992, 66 (05) : 951 - 957
  • [2] Burden of liver diseases in the world
    Asrani, Sumeet K.
    Devarbhavi, Harshad
    Eaton, John
    Kamath, Patrick S.
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : 151 - 171
  • [3] Life expectancy of adult liver allograft recipients in the UK
    Barber, K.
    Blackwell, J.
    Collett, D.
    Neuberger, J.
    [J]. GUT, 2007, 56 (02) : 279 - 282
  • [4] Controlling for continuous confounders in epidemiologic research
    Brenner, H
    Blettner, M
    [J]. EPIDEMIOLOGY, 1997, 8 (04) : 429 - 434
  • [5] Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥40: A retrospective cohort study
    Cardoso, Filipe S.
    Karvellas, Constantine J.
    Kneteman, Norman M.
    Meeberg, Glenda
    Fidalgo, Pedro
    Bagshaw, Sean M.
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 29 (04) : 185 - 191
  • [6] Chenery Hollis., 1975, Patterns of Development, 1950-1983
  • [7] Clinical states of cirrhosis and competing risks
    D'Amico, Gennaro
    Morabito, Alberto
    D'Amico, Mario
    Pasta, Linda
    Malizia, Giuseppe
    Rebora, Paola
    Valsecchi, Maria Grazia
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 (03) : 563 - 576
  • [8] SIMPLIFIED MODELS OF SCREENING FOR CHRONIC DISEASE - ESTIMATION PROCEDURES FROM MASS-SCREENING PROGRAMS
    DAY, NE
    WALTER, SD
    [J]. BIOMETRICS, 1984, 40 (01) : 1 - 14
  • [9] Predicting outcome after liver transplantation: Utility of the model for end-stage liver disease and a newly derived discrimination function
    Desai, NM
    Mange, KC
    Crawford, MD
    Abt, PL
    Frank, AM
    Markmann, JW
    Velidedeoglu, E
    Chapman, WC
    Markmann, JF
    [J]. TRANSPLANTATION, 2004, 77 (01) : 99 - 106
  • [10] How to improve long-term outcome after liver transplantation?
    Durand, Francois
    [J]. LIVER INTERNATIONAL, 2018, 38 : 134 - 138